Last updated on: 1/22/2009 | Author: ProCon.org

Mark A.R. Kleiman, PhD Biography

Title:
Professor of Public Policy at the NYU Marron Institute of Urban Management
Position:
Pro to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“Cannabis is almost certainly a useful treatment for at least some patients with several different diagnoses, and ought to be so recognized by the FDA and therefore sold lawfully at pharmacies under physicians’ prescription. I keep hoping that the National Institute on Drug Abuse will relax the policy which has effectively prevented researchers from acquiring cannabis to use in clinical research, and that the medical marijuana advocates will devote some tiny fraction of their lititigation-and-petitioning budget to the medical research that could take this issue off the table politically.”

“Get Your Red-Hot Medical Marijuana Here,” www.samefacts.com, Mar. 4, 2004

Theoretical Expertise Ranking:
    Experts
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
Involvement and Affiliations:
  • Professor of Public Policy, NYU Marron Institute of Urban Management and NYU Wagner
  • Chairman, BOTEC Analysis Corporation
  • Former Professor of Public Policy, UCLA School of Public Affairs
  • Director, Drug Policy Analysis Program, UCLA School of Public Affairs
  • Co-Director, Jacob Marschak Interdisciplinary Colloquium on Mathematics in the Social Sciences
  • Thomas C. Schelling Visiting Professor, University of Maryland School of Public Policy, Fall 2006
  • Recipient, UCLA Public Affairs Society Undergraduate Teaching Award, 2006
  • Adjunct Scholar, Center for American Progress
  • Research Fellow, Program in Criminal Justice Policy and Management, John F. Kennedy School of Government, Harvard University
  • Chairman of the Board, BOTEC Analysis Corporation (Cambridge, Massachusetts)
  • Co-director, Drug Policy Project, Federation of American Scientists
  • Editor, Drug Policy Analysis Bulletin
  • Received the Aaron Wildavsky Book Award for Against Excess, 1993
Education:
  • PhD, Public Policy, Harvard University, John F. Kennedy School of Government
  • MA, Public Policy, Harvard University, John F. Kennedy School of Government
  • BA, Economics, Philosophy, Political Science, Haverford College
Other:
  • None found